Antiangiogenic therapies, particularly VEGF pathway inhibition, are known to reduce the abnormally thickened vascular membrane to more normal levels, which is strongly associated with improved vascular morphology and function, and finally response to irradiation in angiogenic brain tumor models [29]. The gene discussed is VEGFA; the disease is brain neoplasm.